Suchen Sie nach Informationen zu Astellas Neues Hauptquartier? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.astellas.com/en/about/corporate-information
Company Name. Astellas Pharma Inc. Headquarters. 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan. Tel. +81-3-3244-3000. Access Map (Google Maps)
https://www.astellas.com/us/about/locations
Astellas Pharma US, Inc. Astellas US Headquarters Northbrook, Illinois 1-800-888-7704. Astellas Pharma Global Development, Inc. Northbrook, Illinois 1-800-888-7704. Astellas Policy and Government Affairs. Washington, D.C 1-202-741-1961. Astellas Research Institute of America LLC. Research San Diego, California 1-847-933-7400. Astellas Venture ...
https://www.astellas.com/us/
Learn more about our commitment to patients and available resources. Call us at (800) 888-7704, M-F, 8AM-7PM CT.
https://www.astellas.com/en/news
Cambridge, UK, and Tokyo, Japan, 05 July 2022: Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), a leader in ...
https://www.astellas.com/en/
Astellas was established in 2005 through merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical CO., Ltd. and has a rich history spanning over 100 years. Annual Report 2021. Annual Report 2021 Integrated with the CSR report.
https://www.astellas.com/us/about/corporate-information
2020 - Astellas acquires Audentes Therapeutics, Inc. to become a global leader in AAV-based genetic medicines. 2020 - Astellas and Adaptimmune Therapeutics plc, Philadelphia, Penn. and Oxfordshire, UK, entered into agreement for T-cell therapies for people with cancer.
https://newsroom.astellas.us/index.php
Astellas Unveils Plans to Open New Biotech Campus in South San Francisco. Jul 5, 2022. Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.
https://www.astellas.com/nl/
Official website for Astellas Pharma EMEA. Learn about Corporate Information, Research & Development and Corporate Social Responsibility (CSR).
https://en.wikipedia.org/wiki/Astellas_Pharma
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. On February 5, 2020, the company announced management changes effective from April 1, 2020. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu.
https://www.astellas.com/en/investors
Stock & Rating Information. Year-end dividend - March 31 Interim dividend - September 30 Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment. Read More.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Astellas Neues Hauptquartier gefunden haben.
